Monitoring changes in the fluorescence of metabolic chromophores, reduced nicotinamide adenine dinucleotide and flavin adenine dinucleotide, and the absorption of cytochromes, is useful to study neuronal activation and mitochondrial metabolism in the brain. However, these optical signals evoked by stimulation, seizures and spreading depression in intact brain differ from those observed in vitro. The responses in vivo consist of a persistent oxidized state during neuronal activity followed by mild reduction during recovery. In vitro, however, brief oxidation is followed by prolonged and heightened reduction, even during persistent neuronal activation. In normally perfused, oxygenated and activated brain tissue in vivo, partial pressure of oxygen (P O2 ) levels often undergo a brief 'dip' that is always followed by an overshoot above baseline, due to increased blood flow (neuronal-vascular coupling). By contrast, in the absence of blood circulation, tissue P O2 in vitro decreases more markedly and recovers slowly to baseline without overshooting. Although oxygen is abundant in vivo, it is diffusion-limited in vitro. The disparities in mitochondrial and tissue oxygen availability account for the different redox responses.
Changes in redox level of mitochondrial respiratory chain components can be monitored in live brain tissue by optical imaging. Changes in fluorescence of metabolic cofactors [i.e. reduced nicotinamide adenine dinucleotide (NADH) z and flavin adenine dinucleotide (FAD)] involved in energy processes, and in the absorption spectrum of cytochromes, provide a measure of their redox level. Mitochondrial energy metabolism is tightly coupled with neuronal activity, and changes in metabolic activity alter the redox level of these cofactors. Optical changes related to redox state have been used for many years to gauge the metabolic activity in brain and in other organs. Relating redox responses to electrical, mechanical or secretory processes has provided a rich source of data on the coupling of metabolic activity to their function. Such investigations in mammalian brain shed light on the mechanism of seizures, of spreading depression (SD) and of hypoxia and ischemia. Recently, however, a discrepancy has become apparent between the pattern of redox changes in intact, perfused brain 'in vivo' * , and isolated preparations of central neurons, tissue slices and slice cultures maintained 'in vitro' y in an organ bath. This essay aims at resolving the apparent discrepancy.
Mitochondrial oxidative metabolism utilizes the substrate pyruvate, derived from glucose, to generate the reduced form of the coenzyme NAD (NADH) from its oxidized form NAD + , in addition to reduced FAD (FADH 2 ) from FAD in the tricarboxylic acid (TCA) cycle (Figure 1) . NADH is also produced during glycolysis, and intercompartmental redox gradients can be resolved between the cytosol and mitochondria through the malate-aspartate shuttle. The subsequent oxidation of NADH and FADH 2 in the electron transport chain establishes a potential across the inner mitochondrial membrane, which enables the production of ATP [1, 2] .
Because NADH is fluorescent when excited with UV light (at 340-370 nm, emission at 450 nm) while NAD + is not, NADH oxidation leads to a decrease in fluorescence. FAD is fluorescent (excitation at 450 nm and emission above 510 nm), so that oxidation of FADH 2 to FAD causes an increase in its fluorescence [3] [4] [5] [6] [7] [8] [9] . The fluorescence of NADH cannot be separated from that of NADPH, but the two cofactors are known to act in concert [10] . The fluorescence of FAD cannot be distinguished from other flavoproteins, but presumably the fraction of the signal that varies with metabolic activity is derived from the FADH 2 -FAD pair [11] .
Cytochrome a,a3 acts at the last step in electron transport, the reduction of O 2 to water at complex IV, while NADH-NAD + , at the other end of the transport chain in complex I, mediates the entry of reducing equivalents ( Figure 1) 
